Nbiocell

CEO

Hello, I am Hosup Jung, CEO of Nbiocell Co., Ltd.

We answer not with extravagant words, but with proven technology.
We have advanced AI- and microfluidics-based nano/micro delivery systems
to ensure active ingredients with low bioavailability reach the body and skin precisely where needed.

By accumulating research — including the lessons from failures —
we enhance everyday efficacy in pharmaceuticals, cosmetics, and medifoods.
We prioritize safety and ethics, validate with data, and collaborate openly
to set global standards for a healthier and more beautiful society.

Nbiocell will transform quality of life through delivery innovation.

CEO

CSO / Ph.D. in Pharmacy Kim Dae-Duk Expert in Oral Drug Delivery Systems
- Professor, College of Pharmacy, Seoul National University
- President, Korean Society of Pharmaceutical Sciences and Technology
- Editor-in-Chief, Journal of Pharmaceutical Investigation
- Prime Minister’s Award, 37th Korean Pharmaceutical Day
- Over 250 publications and patents including Nature Nanotechnology (IF 40.03)
CTO / Ph.D. in Engineering Kwak Moon-Kyu Expert in Microfluidic Devices & Mass Production Systems
- Professor, School of Mechanical Engineering, Kyungpook National University
- Vice President for Research, Kyungpook National University
- Specialist in functional surface fabrication and scalable microfluidic manufacturing technologies
Co-CTO / Ph.D. in Engineering Jeong Hoon-Ui Expert in Biomimetic Transdermal Patches
- Professor, School of Mechanical Engineering, UNIST
- Ph.D. in Mechanical Engineering, Seoul National University
- Postdoctoral Research Fellow, UC Berkeley / KAUST
- Expert in biocompatible micro/nano structures and adhesive patch technologies